Neuro-ophthalmic deficits after head trauma.

about

Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury Assessing subacute mild traumatic brain injury with a portable virtual reality balance device.

P2860

Q28551414-A048B0BB-48D3-40FE-9AD6-B7776DB4A547 Q48484205-1749CE08-5A41-4F8F-A80A-5C7944C29BE1

P2860

Neuro-ophthalmic deficits after head trauma.

Item

http://www.wikidata.org/entity/Q38136584

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Neuro-ophthalmic deficits after head trauma.

@en

type

Item

label

Neuro-ophthalmic deficits after head trauma.

@en

prefLabel

Neuro-ophthalmic deficits after head trauma.

@en

P1476

Neuro-ophthalmic deficits after head trauma.

@en

P2093

Gregory P Van Stavern

http://www.w3.org/2001/XMLSchema#string

Sarah M Jacobs

http://www.w3.org/2001/XMLSchema#string

P2860

The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters

Inflammatory response following diffuse axonal injury

Perceptual relearning of complex visual motion after V1 damage in humans

The MRC CRASH Trial: study design, baseline data, and outcome in 1000 randomised patients in the pilot phase.

Early metabolic crisis-related brain atrophy and cognition in traumatic brain injury.

Neuro-ophthalmic manifestations of head trauma.

Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

P2888

s11910-013-0389-5

P304

389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-013-0389-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256501593

http://www.w3.org/2001/XMLSchema#string

P6179

1035103148

http://www.w3.org/2001/XMLSchema#string

P698

24027004

http://www.w3.org/2001/XMLSchema#string

Neuro-ophthalmic deficits after head trauma.

about

P2860

P2860

Neuro-ophthalmic deficits after head trauma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698